Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849147 · ClinicalTrials.gov registry record · Phase 2
Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)
A Phase 2 study of Lymphoma, B-Cell and Leukemia, Myeloid, Acute, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
- 17
- Study locations
NCT00849147 is a Phase 2 study of Lymphoma, B-Cell and Leukemia, Myeloid, Acute that has completed, run by Medical College of Wisconsin. The registered enrollment target is 55 participants, below the 200-participant average among 31 other Lymphoma, B-Cell trials with a reported enrollment target (72% lower). The trial reports 17 study locations across 14 states.
The verdict
NCT00849147, a Phase 2 study of Lymphoma, B-Cell and Leukemia, Myeloid, Acute, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
- 17
- Study locations
Study Summary
Bone marrow transplants are one treatment option for people with leukemia or lymphoma. Family members or unrelated donors with a similar type of bone marrow usually donate their bone marrow to the transplant patients. This study will evaluate the effectiveness of a new type of bone marrow transplant-one that uses lower doses of chemotherapy and bone marrow donated from family members with only partially matched bone marrow-in people with leukemia or lymphoma.
Conditions Studied
Interventions
- BIOLOGICAL Haploidentical Bone Marrow Transplantation
- BIOLOGICAL GVHD prophylaxis
Study Locations (17)
California
- City of Hope National Medical Center - Duarte
- University of California San Diego Medical Center - La Jolla
Maryland
- University of Maryland, Greenbaum Cancer Center - Baltimore
- Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center (SKCCC) - Baltimore
Texas
- Baylor University Medical Center - Dallas
- Texas Transplant Institute - San Antonio
Florida
- University of Florida College of Medicine (Shands) - Gainesville
Georgia
- Bone Marrow Transplant Group of Georgia, Northside Hospital - Atlanta
Hawaii
- Kapi'olani Medical Center for Women and Children, University of Hawaii - Honolulu
Massachusetts
- DFCI, Massachusetts General Hospital - Boston
Michigan
- Karmanos Cancer Institute, Children's Hospital of Michigan - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2008-10 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00849147
The ClinicalTrials.gov registry entry for NCT00849147 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 200-participant average among 31 other Lymphoma, B-Cell trials with a reported enrollment target (72% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Lymphoma, B-Cell appearing as the primary indexed condition, and to 2 interventions - of which Haploidentical Bone Marrow Transplantation is the first listed.
NCT00849147 reports 17 study locations spanning 14 distinct geographic areas - top geographies include California, Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT00849147 about?
NCT00849147 is a clinical study titled "Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)". Bone marrow transplants are one treatment option for people with leukemia or lymphoma. Family members or unrelated donors with a similar type of bone marrow usually donate their bone marrow to the transplant patients. This study will evaluate the effectiveness of a new type of bone marrow transplant...
What is the current status of trial NCT00849147?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2008-10. Estimated completion is 2013-11.
What conditions does trial NCT00849147 study?
This clinical trial studies the following conditions: Lymphoma, B-Cell, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular.
What interventions are being tested in trial NCT00849147?
The interventions under investigation include: Haploidentical Bone Marrow Transplantation (BIOLOGICAL), GVHD prophylaxis (BIOLOGICAL).
Who is sponsoring clinical trial NCT00849147?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00849147 being conducted?
This trial has 17 study locations across California, Florida, Georgia, Hawaii, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma, B-Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
RECRUITING · Phase 2
-
A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
ACTIVE NOT RECRUITING · Phase 2
-
Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma
ACTIVE NOT RECRUITING · Phase 2
-
Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
COMPLETED · Phase 2
-
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
COMPLETED · Phase 2
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.